Should we test hepatitis C virus genotype and viraemia level in patients with chronic hepatitis C?

Journal of Viral Hepatitis

Volumn 4, Issue 5, 1997, Pages 285-292

  Isaacson, A H ^a   Davis, G L ^a   Lau, J Y N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Diagnostics; Epidemiology; Genotype; Hepatitis; Hepatitis C; Management; Treatment; Viraemia

Indexed keywords

BLOOD; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; REVIEW; VIREMIA; VIROLOGY;

GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; VIREMIA;

EID: 0031227530     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00065.x     Document Type: Review

References (48)

1. Ogata N, Alter JH, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3391-3396.
2. Okamoto H, Kojima M, Okada S et al. Genetic drift of hepatitis C virus during a 8.2-year infection in a chimpanzee: variability and stability. J Virol 1992; 190: 894-899.
3. Mizokami M, Gobojori T, Lau JYN. Molecular evolutionary Medicine - its application to the study of hepatitis C virus. Gastroenterology 1994; 107: 1181-1182.
4. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-583.
5. Simmonds P, Alberti A, Bonino F et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-1324.
6. Marousis CG, Lau JYN. Genetic heterogeneity of hepatitis C virus and its clinical implications. Dig Dis 1997; in press.
7. Ohno T, Lau JYN. The gold standard, accuracy, and the current concepts: hepatitis C virus genotype and viremia. Hepatology 1996; 24: 1312-1315.
8. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infections sources. J Gen Virol 1992; 73: 673-679.
9. Chayama K, Tsubota A, Abase Y et al. Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol 1993; 8: 150-156.
10. Stuyver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-1102.
11. McOmish F, Yap PL, Dow BC et al. Geographical distribution of hepatitis C virus genotypes in blood donors - an international collaborative survey. J Clin Microbiol 1994; 32: 884-892.
12. Davidson F, Simmonds P, Fergussion JC et al. Survey of major genotypes and subtypes of hepatitis C virus using restriction fragment length polymorphism of sequences amplified from the 5 non-coding region. J Hepatol 1992; 14: 35-40.
13. Tsukiyama-Kohara K, Kohara M, Yamaguchi K et al. A second group of hepatitis C viruses. Virus Genes 1991; 5: 243-254.
14. McOmish F, Chan SW, Dow BC et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7-13.
15. Machida A, Ohnuma H, Tsud F et al. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology 1992; 16: 886-891.
16. Lau JYN, Mizokami M, Kolberg JA et al. Application of six hepatitis C virus subtyping systems to sera of patients with chronic hepatitis C in the United States. J Infect Dis 1994; 171: 281-289.
17. McOmish F, Chan SW, Dow BC et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serology reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7-13.
18. Dussaix E, Charnaux N, Laurent-Puig P, Chopineau S, Laurian Y, Buffet C. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody. J Clin Microbiol 1994; 32: 2071-2075.
19. Marousis CG, Quan S, Davis GL et al. Immunoreactivity of hepatitis C virus core antigen in chronic hepatitis C. J Hepatol 1997; 26: 446-452.
20. Dhaliwal SK, Prescott LE, Dow BC et al. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol 1996; 48: 184-190.
21. Davis GL, Lau JYN. Hepatitis C. In: Bockus; Haubrich WS, Schoffner F, Berk JE, eds. Bockus: Gastroenterology, 5th edn. Philadelphia: W.B. Saunders Co., 1995: 2082-2114.
22. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechet C and the Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161-166.
23. Pozzato G, Kaneko S, Moretti F et al. Different genotypes of hepatitis C virus are associated with different severity of chronicliver diseases. J Med Virol 1994; 43: 291-296.
24. Qu D, Li JS, Vitvitski L et al. Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II. J Hepatol 1994; 21: 70-75.
25. Koboyashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural history of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695-699.
26. Zhou S, Terrault NA, Ferrell L et al. Severity of liver disease in liver transplant recipients with hepatitis C virus infection: relationship to genotypes and level of viremia. Hepatology 1996; 24: 1041-1046.
27. Lau JYN, Davis GL, Prescott LE et al. and the Hepatitis Interventional Therapy Group. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen in tertiary referral centers in the United States. Ann Intern Med 1996; 124: 868-876.
28. Davis GL, Lau JYN. Factors predictive of response to interferon. Hepatology 1997; in press.
29. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994; 20: 24S-27S.
30. Feray C, Gigou M, Samuel D et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1088-96.
31. Gane EJ, Naoumov NV, Qian KP et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167-177.
32. Young KK, Archer JJ, Yokosuka O, Omata M, Resnick RM. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparsion with nested amplification and antibody testing. J Clin Microbiol 1995; 33: 654-657.
33. Lau JYN, Davis GL, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-1504.
34. Coelho-Little E, Jeffers LJ, Bartholomew M, Reddy KR, Schiff ER, Dailey PJ. Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C. J Hepatol 1995; 22: 248-249.
35. Gonzalez-Peralta RP, Fang JWS, Davis GL et al. Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C. Dig Dis Sci 1995; 40: 1595-1601.
36. Lau GKK, Davis GL, Wu PC, Gish RG, Balart LA, Lau JYN. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in-situ reverse transcription polymerase chain reaction. Hepatology 1996; 23: 1318-1323.
37. Gretch DR, dela Rosa C, Carithers RL, Willson RA, Williams B, Corey L. Assessment of hepatitis C viremia using molecular amplification technologies: correlation and clinical implications. Ann Intern Med 1995; 123: 321-329.
38. Smith DB, Davidson F, Yap PL et al. Levels of hepatitis C virus in blood donors infected with different virus genotypes. J Infect Dis 1996; 173: 727-730.
39. Zeuzem S, Franke A, Lee JH, Herrmann G, Ruster B, Roth WK. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests and histology. Hepatology 1996; 24: 1003-1009.
40. Orito E, Mizokami M, Suzuki K et al. Loss of serum HCV RNA at week 4 of interferon alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis. J Med Virol 1995; 46: 109-115.
41. Yun ZB, Reichard O, Chen M et al. Serum hepatitis C virus RNA levels in chronic hepatitis C - importance for outcome of interferon alfa-2b treatment. Scand J Infect Dis 1994; 26 263-270.
42. Lau JYN, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL. Discrepancy between biochemical and virological response to interferon-alpha therapy in chronic hepatitis C. Lancet 1993; 342: 1208-1209.
43. Chazouilleres O, Kim M, Combs C et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994-999.
44. Lau JYN, Davis GL, Brunson ME et al. Hepatitis C virus infection in renal transplant recipients. Hepatology 1993; 18: 1027-1031.
45. Lim H, Lau GKK, Davis GL, Dolson D, Lau JYN. Cholestatic hepatitis in a patient with organ transmitted hepatitis C virus infection. Gastroenterology 1994; 106: 248-251.
46. Kim-Schluger L, Sheiner PA, Thung SN et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 25: 971-976.
47. Dickson R, Caldwell SH, Ishitani MB et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996; 61: 701-705.
48. Lau JYN, Simmonds P, Urdea MS. Implications of variations of 'conserved' regions of hepatitis C virus genome. Lancet 1995; 346: 425-426.